Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for oscillopsia in multiple sclerosis
2008-000490-37Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Memantine with Placebo (2 arms). Primary endpoint: Primary reduction in oscillopsia and improvement in visual acuity. Started Mar 2008; status: terminated.
02
Drugs
memantine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2008-000490-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000490-37.